Literature DB >> 3549262

Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat.

C Cade, A W Norman.   

Abstract

It has been previously demonstrated in this laboratory that vitamin D3 is essential for normal insulin secretion from the perfused rat pancreas. More recently we have shown, consistent with a physiological role for the vitamin in this process, that vitamin D-deficient rats exhibit impaired glucose clearance and insulin secretion, as monitored during iv glucose tolerance tests. Both of these parameters are significantly improved after vitamin D repletion independently of nutritional factors and the prevailing plasma calcium and phosphorus concentrations. In this present study the dose response and time course of effect of a single sc injection of the active metabolite 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] on glucose tolerance and insulin secretion were investigated. The impaired glucose clearance of vitamin D-deficient rats (KG = 912 +/- 37, where KG is a function of glucose tolerance) was markedly improved as early as 3 h after acute 1,25(OH)2D3 (1.3 nmol; 20 U) administration (KG = 676 +/- 13), and this clearance was maintained for up to 20 h (KG = 688 +/- 24). This improvement corresponded to enhanced glucose-induced insulin secretion. By 3 h after 1,25-(OH)2D3 substitution, the peak of insulin secretion was elevated by 170% of control values, independently of a significant increase in plasma phosphorus or plasma calcium concentrations. The hypoglycemic propensity of 1,25-(OH)2D3 was also dose dependent. Glucose tolerance was significantly improved (KG = 573 +/- 33), and insulin secretion was maximal (250% of control) after administration of only 0.26 nmol (4 U) 1,25-(OH)2D3. Higher concentrations of seco-steroid, although stimulatory, proved less effective. This study demonstrates a rapid response (within 3 h) to the potentiating action of 1,25-(OH)2D3 on in vivo insulin secretion and glucose clearance in the vitamin D-deficient rat. A dose dependence of this hypoglycemic action is also established.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549262     DOI: 10.1210/endo-120-4-1490

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  27 in total

1.  Vitamin D and pancreatic islet function. I. Time course for changes in insulin secretion and content during vitamin D deprivation and repletion.

Authors:  H Labriji-Mestaghanmi; B Billaudel; P E Garnier; W J Malaisse; B C Sutter
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

Review 2.  Vitamin D and diabetes mellitus: Causal or casual association?

Authors:  M Grammatiki; E Rapti; S Karras; R A Ajjan; Kalliopi Kotsa
Journal:  Rev Endocr Metab Disord       Date:  2017-06       Impact factor: 6.514

3.  Vitamin D and vitamin A receptor expression and the proliferative effects of ligand activation of these receptors on the development of pancreatic progenitor cells derived from human fetal pancreas.

Authors:  Ka Yan Ng; Man Ting Ma; Kwan Keung Leung; Po Sing Leung
Journal:  Stem Cell Rev Rep       Date:  2011-03       Impact factor: 5.739

Review 4.  The Role of Vitamin D in the Prevention of Type 2 Diabetes: To D or Not to D?

Authors:  Edith Angellotti; Anastassios G Pittas
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

Review 5.  Role of vitamin D in diabetes mellitus and chronic kidney disease.

Authors:  Akio Nakashima; Keitaro Yokoyama; Takashi Yokoo; Mitsuyoshi Urashima
Journal:  World J Diabetes       Date:  2016-03-10

6.  Regulatory effect of 1,25-dihydroxyvitamin D3 on insulin release and calcium handling via the phospholipid pathway in islets from vitamin D-deficient rats.

Authors:  B J Billaudel; P M Bourlon; B C Sutter; A G Faure-Dussert
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

7.  Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial.

Authors:  Joanna Mitri; Bess Dawson-Hughes; Frank B Hu; Anastassios G Pittas
Journal:  Am J Clin Nutr       Date:  2011-06-29       Impact factor: 7.045

Review 8.  Vitamin D and diabetes.

Authors:  Joanna Mitri; Anastassios G Pittas
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

9.  Control of TCF-4 expression by VDR and vitamin D in the mouse mammary gland and colorectal cancer cell lines.

Authors:  Marcy E Beildeck; Md Islam; Salimuddin Shah; Joellen Welsh; Stephen W Byers
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240

10.  Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study.

Authors:  Susan Cheng; Joseph M Massaro; Caroline S Fox; Martin G Larson; Michelle J Keyes; Elizabeth L McCabe; Sander J Robins; Christopher J O'Donnell; Udo Hoffmann; Paul F Jacques; Sarah L Booth; Ramachandran S Vasan; Myles Wolf; Thomas J Wang
Journal:  Diabetes       Date:  2009-10-15       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.